World’s First Bedside Genetic Test Provides Results in 60 Minutes without Need to Send Specimen to the Central Pathology Laboratory

Clinical trial demonstrated value of genetic point-of-care testing and a rapid time to result Here’s a milestone in genetic testing that should catch the attention of pathologists and clinical laboratory managers everywhere. It is a point-of-care (POC) genetic test that is reliable enough to be used in a clinical trial. The clinical trial was called RAPID GENE. It was conducted at the University of Ottawa Heart Institute (UOHI). The study enrolled 200 patients who were being treated with...

Stanford Study Shows How Pathologists May Eventually Use the Whole Human Genome for Diagnostic Purposes

Researchers use patient’s whole genome to predict his risk for 55 different health conditions For pathologists, the day draws ever closer when they will use a patient’s whole genome sequence for diagnostic purposes. That’s the implication from research being done at the University of Stanford Medical School where scientists recently made a leap forward in advancing practical application of the human genome to patient care. Stanford researchers recently announced that, for the first time, a...
;